Get access to our best features
Get access to our best features
Published 2 months ago

How Beam, Up 28% Today, Is Planning To Take On Crispr

Summary by Investor's Business Daily
Beam stock launched to a year high Tuesday as enthusiasm grows for its next-generation form of gene editing, a rival to CRISPR.

0 Articles

All
Left
Center
Right
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe
Ground News Article Assistant
Not enough coverage to generate an Article Assistant.

Bias Distribution

  • 100% of the sources lean Right
100% Right
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)